BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16957652)

  • 1. Argon beam coagulation as an adjuvant for local control of giant cell tumor.
    Lewis VO; Wei A; Mendoza T; Primus F; Peabody T; Simon MA
    Clin Orthop Relat Res; 2007 Jan; 454():192-7. PubMed ID: 16957652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone.
    Dürr HR; Maier M; Jansson V; Baur A; Refior HJ
    Eur J Surg Oncol; 1999 Dec; 25(6):610-8. PubMed ID: 10556009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case analysis on treatment and recurrence of giant cell tumor of bone].
    Zhang Z; Zhu B; Sun T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of phenol and argon beam coagulation as adjuvant therapies in the treatment of stage 2 and 3 benign-aggressive bone tumors.
    Benevenia J; Patterson FR; Beebe KS; Abdelshahed MM; Uglialoro AD
    Orthopedics; 2012 Mar; 35(3):e371-8. PubMed ID: 22385449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
    Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
    Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
    Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
    Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
    Gouin F; Dumaine V;
    Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?
    Gaston CL; Bhumbra R; Watanuki M; Abudu AT; Carter SR; Jeys LM; Tillman RM; Grimer RJ
    J Bone Joint Surg Br; 2011 Dec; 93(12):1665-9. PubMed ID: 22161931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with recurrence of primary aneurysmal bone cysts: is argon beam coagulation an effective adjuvant treatment?
    Steffner RJ; Liao C; Stacy G; Atanda A; Attar S; Avedian R; Peabody TD
    J Bone Joint Surg Am; 2011 Nov; 93(21):e1221-9. PubMed ID: 22048101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell tumor of bone. Curettage and cement reconstruction.
    Bini SA; Gill K; Johnston JO
    Clin Orthop Relat Res; 1995 Dec; (321):245-50. PubMed ID: 7497676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The analysis of the treatment of giant cell tumor of the pelvis and sacrum].
    Guo W; Tang XD; Li X; Ji T; Sun X
    Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(7):501-5. PubMed ID: 18785558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant.
    Oh JH; Yoon PW; Lee SH; Cho HS; Kim WS; Kim HS
    Int Orthop; 2006 Dec; 30(6):490-4. PubMed ID: 16736146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy for giant cell tumors of bone.
    Feigenberg SJ; Marcus Jr RB; Zlotecki RA; Scarborough MT; Berrey BH; Enneking WF
    Clin Orthop Relat Res; 2003 Jun; (411):207-16. PubMed ID: 12782877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thoracoscopic parietal pleural argon beam coagulation versus pleural abrasion in the treatment of primary spontaneous pneumothorax.
    Bobbio A; Ampollini L; Internullo E; Caporale D; Cattelani L; Bettati S; Carbognani P; Rusca M
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):6-8. PubMed ID: 16337391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint salvage for pathologic fracture of giant cell tumor of the lower extremity.
    Deheshi BM; Jaffer SN; Griffin AM; Ferguson PC; Bell RS; Wunder JS
    Clin Orthop Relat Res; 2007 Jun; 459():96-104. PubMed ID: 17417093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional outcome of en bloc excision and osteoarticular allograft replacement with the Sauve-Kapandji procedure for Campanacci grade 3 giant-cell tumor of the distal radius.
    Szabo RM; Anderson KA; Chen JL
    J Hand Surg Am; 2006 Oct; 31(8):1340-8. PubMed ID: 17027797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary malignant giant-cell tumor of bone has high survival rate.
    Domovitov SV; Healey JH
    Ann Surg Oncol; 2010 Mar; 17(3):694-701. PubMed ID: 19902306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-operation results in osteoarthritic change of knee joints in patients with giant cell tumor of bone.
    Suzuki Y; Nishida Y; Yamada Y; Tsukushi S; Sugiura H; Nakashima H; Ishiguro N
    Knee; 2007 Oct; 14(5):369-74. PubMed ID: 17601737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell tumor of the hand: superior results with curettage, cryosurgery, and cementation.
    Wittig JC; Simpson BM; Bickels J; Kellar-Graney KL; Malawer MM
    J Hand Surg Am; 2001 May; 26(3):546-55. PubMed ID: 11418922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
    Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
    World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.